Diet, Neurotransmitters, and Behavior

  • Robin B. Kanarek
  • Robin Marks-Kaufman


In the preceding chapters, we have seen that nutritional variables play important roles in the functioning of the central nervous system and sub-sequent behavior. Deficiencies of essential nutrients can impair the function and development of the CNS, and result in profound behavioral disturbances. Brain functioning and behavior can also be adversely affected by contamination of food supplies with heavy metals (e. g., lead, mercury, and aluminum). In these situations, relatively long-term nutritional deficiencies or exposure to environmental toxins are necessary before alterations in brain functioning and behavior are observed.


Tardive Dyskinesia Serotonergic Neuron Seasonal Affective Disorder Serotonergic Activity Large Neutral Amino Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. American Psychiatric Association. 1987. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised, pp. 213–233. Washington, D.C., American Psychiatric Association.Google Scholar
  2. Anderson, G. H. 1979. Control of protein and energy intake: Role of plasma amino acids and brain neurotransmitters. Canadian Journal of Physiology and Pharmacology 57: 1043–1057.CrossRefGoogle Scholar
  3. Aquilonius, S. and Eckernas, S. 1977. Choline therapy in Huntington’s chorea. Neurology 27: 887–889.Google Scholar
  4. Bartus, R. T., R. I. Dean, B. Beer, and A. S. Lippa. 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408–417.CrossRefGoogle Scholar
  5. Batey, S. R. 1989. Schizophrenic disorders. In Pharmacotherapy: A Pathophysio-logical Approach, ed. J. T. DiPiro et al., pp. 714–728. New York: Elsevier.Google Scholar
  6. Blundell, J. E. 1984. Serotonin and appetite. Neuropharmacology 23: 1537–1551.CrossRefGoogle Scholar
  7. Blundell, J. E. and A. J. Hill. 1987. Influence of tryptophan on appetite and food selection in man. In Amino Acids in Health and Disease: New Perspectives, ed. S. Kaufman, pp. 403–419. New York: Alan R. Liss.Google Scholar
  8. Branchey, M. H., L. B. Branchey, N. M. Bark, and M. A. Richardson. 1979. Lecithin in the treatment of tardive dyskinesia. Communications in Psychophar- macology 3: 303–307.Google Scholar
  9. Carlsson, A. 1987. Commentary. Integrative Psychiatry 5: 238–239.Google Scholar
  10. Clauw, D. J., D. J. Nashel, A. Umhau, and P. Katz. 1990. Tryptophan-associated eosinophilic connective-tissue disease. Journal of the American Medical Association 263: 1502–1506.CrossRefGoogle Scholar
  11. Cohen, E. L. and R. J. Wurtman. 1976. Brain acetylcholine: Control by dietary choline. Science 191: 561–562.CrossRefGoogle Scholar
  12. Davis, K. L., L. E. Hollister, J. D. Barchas, and P. A. Berger. 1976. Life Sciences 19: 1507–1516.CrossRefGoogle Scholar
  13. Ereshefsky, L., R. Rospond, and M. Jann. 1989. Organic brain syndromes, Alzheimer type. In Pharmacotherapy: A Pathophysiological Approach, ed. J. T. DiPiro et al., pp. 678–696. New York: Elsevier.Google Scholar
  14. Fernstrom, J. D. 1981. Effects of precursors on brain neurotransmitter synthesis and brain functions. Diabetologia 20: 281–289.CrossRefGoogle Scholar
  15. Fernstrom, J. D. 1986. Acute and chronic effects of protein and carbohydrate ingestion on brain tryptophan levels and serotonin synthesis. Nutrition Reviews 44 (Suppl.): 25 - 36.Google Scholar
  16. Fernstrom, J. D. 1988. Tryptophan, serotonin and carbohydrate appetite: Will the real carbohydrate craver please stand up? Journal of Nutrition 118: 1417–1419.Google Scholar
  17. Fernstrom, J. D. and R. J. Wurtman. 1971a. Brain serotonin content: Physiological dependence on plasma tryptophan levels. Science 173: 149–152.Google Scholar
  18. Fernstrom, J. D. and R. J. Wurtman. 1971b. Brain serotonin content: Increase following ingestion of carbohydrate diet. Science 174: 1023–1025.CrossRefGoogle Scholar
  19. Fernstrom, J. D. and R. J. Wurtman. 1974. Nutrition and the brain. Scientific American 230: 84–91.CrossRefGoogle Scholar
  20. Garattini, S. 1989. Further comments. Integrative Psychiatry 6: 235–238.Google Scholar
  21. Gelenberg, A. J., J. C. Doller-Wojcik, and J. H. Growden. 1979. Choline and lecithin in the treatment of tardive dyskinesia: Preliminary results from a pilot study. American Journal of Psychiatry 136: 772–776.Google Scholar
  22. Gelenberg, A. J., J. Wojcik, W. E. Falk, B. Bellinghausen, and A. B. Joseph. 1989. CDP-choline for the treatment of tardive dyskinesia: A small negative series. Comprehensive Psychiatry 30: 1–4.CrossRefGoogle Scholar
  23. Growden, J. H. 1979. Neurotransmitter precursors in the diet: Their use in the treatment of brain disease. In Nutrition and the Brain, vol. 3, ed. R. J. Wurtman and J. J. Wurtman, pp. 117–181. New York: Raven Press.Google Scholar
  24. Growden, J. H., E. L. Cohen, and R. J. Wurtman. 1977. Huntington’s disease: Clinical and chemical effects of choline administration. Annals of Neurology 1: 418–422.CrossRefGoogle Scholar
  25. Growden, J. H., M. J. Hirsch, R. J. Wurtman, and W. Wiener. 1977. Oral choline administration to patients with tardive dyskinesia. New England Journal of Medicine 297: 524–527.CrossRefGoogle Scholar
  26. Growden, J. H., A. J. Gelenberg, J. Doller, M. J. Hirsch, and R. J. Wurtman. 1978. Lecithin can suppress tardive dyskinesia. New England Journal of Medicine 298: 1029–1030.Google Scholar
  27. Hartman, E. and C. Spinweber. 1979. Sleep induced by 1-tryptophan: Effects of dosages within normal dietary intake. Journal of Nervous and Mental Disorders 167: 497–499.CrossRefGoogle Scholar
  28. Hartmann, E., C. Spinweber, and J. C. Ware. 1983. Effect of amino acids on quantified sleepiness. Nutrition and Behavior 1: 179–183.Google Scholar
  29. Hrboticky, N., L. A. Leiter, and G. H. Anderson. 1985. Effects of L-tryptophan on short-term food intake in lean men. Nutrition Research 5: 595–600.CrossRefGoogle Scholar
  30. Jackson, I. V., E. A. Nuttall, and J. Perez-Cruet. 1979. Treatment of tardive dyskinesia with lecithin. American Journal of Psychiatry 136: 1458–1459.Google Scholar
  31. Jouvet, M. 1968. Insomnia and decrease of cerebral 5-hydroxytryptamine after destruction of the raphe system in the cat. Advances in Pharmacology 6: 265–279.CrossRefGoogle Scholar
  32. Kanarek, R. B. 1987. Neuropharmacological approaches to studying diet selection. In Amino Acids in Health and Disease: New Perspectives, ed. S. Kaufman, pp. 383–401. New York: Alan R. Liss.Google Scholar
  33. Leathwood, P. D. 1986. Neurotransmitter precursors: From animal experiments to human applications. Nutrition Reviews 44 (Suppl.): 193–204.Google Scholar
  34. Medsger, T. A. 1990. Tryptophan-induced eosinophilia–myalgia syndrome. New England Journal of Medicine 322: 926–927.CrossRefGoogle Scholar
  35. Nathan, C. and Y. Rolland. 1987. Pharmacological treatments that affect CNS activity: Serotonin. Annals of the New York Academy of Sciences 499: 277–296.CrossRefGoogle Scholar
  36. Pollack, J. D. and N. Rowland. 1981. Peripherally administered serotonin decreases food intake in rats. Pharmacology, Biochemistry and Behavior 15: 179–183.CrossRefGoogle Scholar
  37. Saminin, R. and S. Garattini. 1990. The pharmacology of serotoninergic drugs affecting appetite. In Nutrition and the Brain, vol. 8, ed. R. J. Wurtman and J. J. Wurtman, pp. 163–192. New York: Raven Press.Google Scholar
  38. Silverstone, T. 1981. Clinical pharmacology of anorectic drugs. In Anorectic Agents Mechanisms of Action, ed. S. Garattini and R. Samanin, pp. 211–222. New York: Raven Press.Google Scholar
  39. Silverstone, T. and E. Goodall. 1984. The clinical pharmacology of appetite sup-pressant drugs. International Journal of Obesity 8 (Suppl. l): 23–33.Google Scholar
  40. Spring, B. J., H. R. Lieberman, G. Swope, and G. S. Garfield. 1986. Effects of carbohydrates on mood and behavior. Nutrition Reviews 44 (Suppl.): 51–60.Google Scholar
  41. Tarsy, D. 1983. History and definition of tardive dyskinesia. Clinical Neurophar-macology 6: 91–99.Google Scholar
  42. Wecker, L. 1990. Choline utilization by central cholinergic neurons. In Nutrition and the Brain, vol. 8, ed. R. J. Wurtman and J. J. Wurtman, pp. 147–162. New York: Raven Press.Google Scholar
  43. Wells, B. G. and P. E. Hayes. 1989. Depressive illness. In Pharmacotherapy: A Pathophysiological Approach, ed. J. T. DiPiro et al., pp. 748–764. New York: Elsevier.Google Scholar
  44. Wurtman, J. J. 1987. Excessive carbohydrate snack intake among a class of obese people. New York Academy of Sciences 499: 197–202.CrossRefGoogle Scholar
  45. Wurtman, R. J. 1987. Nutrients affecting brain composition and behavior. Integrative Psychiatry 5: 226–257.Google Scholar
  46. Wurtman, R. J., F. Hefti, and E. Melamed. 1981. Precursor control of neuro–transmitter synthesis. Pharmacological Reviews 32: 315–335.Google Scholar
  47. Wurtman, J. J. and R. J. Wurtman. 1984. D-fenfluramine selectively decreases carbohydrate but not protein intake in obese subjects. International Journal of Obesity 8 (Suppl. l): 79–84.Google Scholar
  48. Wurtman, R. J. and J. J. Wurtman. 1989. Carbohydrates and depression. Scientific American January: 68–75.Google Scholar
  49. Wyatt, R. J., K. Engelman, D. J. Kupfer, D. H. Fram, A. Sjoerdsma, and F. Snyder. 1970. Effects of 1-tryptophan (a natural sedative) on human sleep. Lancet 2: 842–846.CrossRefGoogle Scholar
  50. Yogman, M. W. 1986. Nutrients and newborn behavior: Neurotransmitters as mediators? Nutrition Reviews 44 (Suppl. 1): 74–77.Google Scholar
  51. Yokogoshi, H. and R. J. Wurtman. 1986. Meal composition and plasma amino acid ratios: Effects of various proteins on carbohydrate, and of various protein concentrations. Metabolism 35: 837–842.CrossRefGoogle Scholar

Copyright information

© Van Nostrand Reinhold 1991

Authors and Affiliations

  • Robin B. Kanarek
    • 1
  • Robin Marks-Kaufman
    • 1
  1. 1.Tufts UniversityMedfordUSA

Personalised recommendations